More Articles

Immunotherapy
Yes, It’s Urgent: Timely Care of Immune-Related Adverse Events

Yes, It’s Urgent: Timely Care of Immune-Related Adverse Events

Jordan McPherson, Pharm.D., M.S., BCOP

Three key tips to help facilitate more timely care collaboration for cancer patients with immune-related adverse events.

COVID-19
Immunomodulators for Patients with COVID-19

Immunomodulators for Patients with COVID-19

Paul M. Szumita, Pharm.D., BCPS, BCCCP, FASHP, FCCM

Evidence-based guidance in the management of hospitalized patients with COVID-19 with a focus on immunomodulators

COVID-19
Antivirals for patients with COVID-19: Now and the Future

Antivirals for patients with COVID-19: Now and the Future

Jeffrey C. Pearson, Pharm.D., BCIDP

Summary of remdesivir for the treatment of COVID-19, as well as other promising antivirals in the pipeline.

Anticoagulation
VTE Prophylaxis for Medically Ill Patients: The History of Pharmacologic Warfare

VTE Prophylaxis for Medically Ill Patients: The History of Pharmacologic Warfare

John Fanikos, R.Ph., MBA

Take a stroll through history exploring the therapeutic options for VTE prophylaxis in medically ill patients

Anticoagulation
Laboratory Monitoring of DOAC Levels: Any Value in That?

Laboratory Monitoring of DOAC Levels: Any Value in That?

Jason R. Vilar, Pharm.D., BCCCP

A discussion of standard and alternative laboratory methods to measure levels of direct-acting oral anticoagulants

Anticoagulation
Making Peripheral Disease the Center of Attention

Making Peripheral Disease the Center of Attention

Zachary Stacy, Pharm.D., M.S., FCCP, BCPS

While peripheral arterial disease affects more than 8 million U.S. patients with the potential for significant cardiovascular complications and death, disease state awareness remains low.

Anticoagulation
Who and When: Re-initiating Anticoagulants After a Bleed

Who and When: Re-initiating Anticoagulants After a Bleed

James S. Kalus, Pharm.D., FASHP

A discussion of the complexities of re-initiating anticoagulants after a bleeding event caused by anticoagulants

Neuromuscular Blockade
Residual Neuromuscular Blockade: Not Just Relevant to the Anesthesiologist

Residual Neuromuscular Blockade: Not Just Relevant to the Anesthesiologist

Rachel C. Wolfe, Pharm.D., M.H.A., BCCCP

Pharmacists are well positioned to advocate for safe management of patients undergoing neuromuscular blockade and reversal and should expand their knowledge on this topic.

C. difficile
Perfect probiotics for <i>C. difficile:</i> what's your gut telling you?

Perfect probiotics for C. difficile: what's your gut telling you?

Kelly R. Reveles, Pharm.D., Ph.D., BCPS

Probiotics may help prevent C. difficile infections, but limitations exist and newer microbiome-targeted therapies offer advantages

C. difficile
Antibiotic Prophylaxis for <i>Clostridioides difficile</i> infection: Helpful or Harmful?

Antibiotic Prophylaxis for Clostridioides difficile infection: Helpful or Harmful?

Anne J. Gonzales-Luna, Pharm.D., BCIDP

Prophylaxis is used to prevent a variety of infections but using antibiotics to prevent C. difficile infection may have the opposite effect.